Noninvasive Brain Stimulation for Nicotine Dependence in Schizophrenia: A Mini Review.

ABSTRACT: Individuals with schizophrenia are 10 times more likely to have a tobacco use disorder than the general population. Up to 80% of those with schizophrenia smoke tobacco regularly, a prevalence three-times that of the general population. Despite the striking prevalence of tobacco use in schizophrenia, current treatments are not tailored to the pathophysiology of this population. There is growing support for use of noninvasive brain stimulation (NIBS) to treat substance use disorders (SUDs), particularly for tobacco use in neurotypical smokers. NIBS interventions targeting the dorsolateral prefrontal cortex have been effective for nicotine dependence in control populations-so much so that transcranial magnetic stimulation is now FDA-approved for smoking cessation. However, this has not borne

SUBMITTER: Ward HB 

PROVIDER: S-EPMC8863675 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature